{
    "organizations": [],
    "uuid": "7b2afd3342d56c8308304f046dc3ea49155b3ef0",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-perrigo-announces-final-fda-approv/brief-perrigo-announces-final-fda-approval-and-planned-launch-for-the-store-brand-otc-equivalent-of-mucinex-dm-maximum-strength-extended-release-tablets-idUSASB0C977",
    "ord_in_thread": 0,
    "title": "BRIEF-Perrigo Announces Final FDA Approval And Planned Launch For The Store Brand OTC Equivalent Of Mucinex DM Maximum Strength Extended Release Tablets",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Perrigo Company Plc:\n* PERRIGO ANNOUNCES FINAL FDA APPROVAL AND PLANNED LAUNCH FOR THE STORE BRAND OTC EQUIVALENT OF MUCINEX® DM MAXIMUM STRENGTH EXTENDED RELEASE TABLETS\n* PERRIGO - ‍FINALIZING PLANS TO LAUNCH CO’S STORE BRAND EQUIVALENT OF MUCINEX DM MAXIMUM STRENGTH FOR 2018 COUGH-COLD SEASON​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-07T22:05:00.000+02:00",
    "crawled": "2018-03-08T17:38:05.029+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "perrigo",
        "company",
        "plc",
        "perrigo",
        "announces",
        "final",
        "fda",
        "approval",
        "planned",
        "launch",
        "store",
        "brand",
        "otc",
        "equivalent",
        "dm",
        "maximum",
        "strength",
        "extended",
        "release",
        "tablet",
        "perrigo",
        "plan",
        "launch",
        "co",
        "store",
        "brand",
        "equivalent",
        "mucinex",
        "dm",
        "maximum",
        "strength",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}